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1. Introduct ion 
Tolbutamidet, which is known for its stimulatory 
action on insulin secretion [8] fails to increase the 
biosynthesis of insulin as judged by the incorporation 
of radioactive l ucine into the insulin fraction of 
pancreatic slices or isolated islets [13, 11]. Tanese t 
al. [12] even described a dose-related inhibition of 
the leucine incorporation i to proinsulin and insulin, 
effected by tolbutamide at low glucose concentrations. 
On the other hand, at 300 mg% glucose astimulation 
of insulin biosynthesis in the presence of tolbutamide 
was reported by these authors. 
Glibenclamide [2], a new potent sulphonylurea, 
exhibited kinetics Of insulin secretion differing from 
those induced by tolbutamide when examined at 
certain glucose concentrations [9, 1 ]. Therefore we 
decided to study the effect of both tolbutamide and 
glibenclamide on incorporation of [3H]leucine into 
the proinsulin and insulin fraction of isolated pan- 
creatic islets at various concentrations of glucose. 
2. Methods 
Pancreatic islets were isolated both from fed male 
Swiss albino mice, strain NMRI, weighing about 30 g 
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and from fed male rats, strain FW 49 Kirchb.-Lemgo- 
Bib., weighing about 250 g. Collagenase, which was 
purchased from Serva, Heidelberg, was used for the 
digestion of pancreatic tissue, as described by Lacy 
and Kostianovsky [4]. 
2.1. Studies o f  leucine incorporation 
Batches of 40 islets of comparable size were in- 
cubated in 1 ml of Krebs-Ringer bicarbonate buffer, 
pH 7.4, supplemented with 17 naturally occurring 
amino acids (20/ag/ml, eucine excluded), bovine 
serum albumin (2 mg/ml, Behringwerke, Marburg) 
and a protease inhibitor (1000 KIU/ml TrasylolfR), 
Bayer Leverkusen) in the presence of [4, 5-3H]L -
leucine (50 oCi, 20 Ci/mmole, Amersham). 
Glucose was present at concentrations of 100 or 
300 mg%, as were tolbutamide and glibenclamide 
(obtained from Farbwerke Hoechst AG, Germany) 
at 100, 250 and 500/ag/ml and 2.5, 5.0 and 10 
t~g/ml, respectively. Incubations were carried out at 
37 ° for 3 hr in an atmosphere of O2:CO 2 (95:5%, 
v/v). 
After the incubations, both the islets and the media 
were quickly frozen together to -28 ° . After thawing, 
trichloroacetic a id was added, yielding a final con- 
centration of 10% w/v, followed by ultrasonic 
disintegration. The precipitated proteins were washed 
with 5% trichloroacetic aeid, dissolved in 1 M acetic 
acid and separated on a calibrated Sephadex G-50 
free column, 1.2 × 55 cm, using 1 M acetic acid as 
eluent at a flow-rate of 10 ml/hr. Radioactivity and 
immunological measurable insulin [6] were determined 
in each fraction of the column and in the pooled 
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peaks. Due to the large number and careful selection 
of the islets in each sample no differences were found 
in the insulin content amongst the batches of each 
40 islets. Thus, direct comparison was made between 
the radioactivity curves obtained from the eluates of 
the islet proteins, based on equal insulin content 
resp. equal number of islets as frequently reported in 
literature. 
The secretion of immunologically measurable 
insulin was estimated hourly during 3 hr of incubation 
in aliquots of the incubation medium. 
2.2. Pulse labelling studies 
The conversion of proinsulin to insulin was also 
studied by pulse labelling the islet proteins. After pre- 
incubation of 40 islets in 1 ml buffer each at 300 
mg% glucose for 1 hr, a pulse of [3H]leucine was 
given for 10, 20 and 30 min. Subsequently, the islets 
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Fig. I. Incorporation of [3H]leueine into the proinsulin (P) and insulin (I) fraction of 40 isolated pancreatic mouse islets after in- 
cubation of the islets for 3 hr in the presence of [3H]leucine at 100 or 300 rag% glucose. Tolbutamide and glibenclamide were 
present at concentrations of 100, 250 and 500 pg/ml and 2.5, 5 and 10 pg/ml, respectively. After precipitation with trichloroace- 
tic acid the islet proteins were fractionated on Sephadex G-$0 fine. The first peak eluting with the void volume represents other 
islet proteins excluded from the gel, the last peak free [3H]leucine. Secretion of insulin into the incubation medium is also shown. 
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were washed with the buffer and incubated for a 
further 2 hr without radioactive and without non 
radioactive l ucine in the presence of tolbutamide 
(250/ag/ml) or glibenclamide (5/~g/ml) and/or 0, 
100 or 300 mg% glucose. Non radioactive l ucine was 
not added on account of the stimulatory action of 
leucine itself on insulin secretion. 
A detailed escription of the methods used in- 
eluding the procedures for identification of the in- 
dividual peaks eluting from the Sephadex column will 
be given elsewhere [ 10]. 
3. Results 
The incorporation f[aH]leucine into proinsulin 
and insulin was depressed at 100 mg% glucose, when 
tolbutamide or glibenclamide was added to the in- 
cubation medium. At 300 mg% glucose, the presence 
of these sulphonylureas reduced the [aH]leucine in. 
corporation into proinsulin and insulin fo about two 
thirds and the half, respectively, as compared with 
the results in the absence of these drugs (fig. 1). In 
none of our 14 experiments was an increase of leucine 
incorporation observed in the presence of sulphonyl- 
ureas at any glucose concentration. The amount of 
inhibition did not differ between the concentrations 
of tolbutamide or glibenclamide which were tested 
(cf. [121 ). 
Insulin secretion was increased by sulphonylureas 
in all experiments. At 300 mg% glucose, stimulation 
of insulin secretion was greater with glibenclamide 
(2.5, 5 and 10/~g/ml) than with tolbutamide (100,, 
250 and 500/ag/ml, respectively,) unlike the findings 
at 100 mg% glucose (fig. 1). 
Essentially identical findings concerning both 
leucine incorporation and insulin secretion were 
obtained in experiments with islets of mice (n = 11) 
and rats (n = 3). 
Studies with pulse labelling of the islets for 20 
and 30 min (fig. 2) showed that conversion of pro- 
insulin to insulin was affected by neither drug. Glucose 
also had no influence on the conversion of proinsulin 
to insulin per se. After a pulse of radioactive l ucine 
for 10 min, only very small amounts of radioactivity 
were found incorporated; no differences were apparent 
between the individual experiments. 
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Fig. 2. Incorporation of [3H]leucine into the proinsutin (P) 
and insulin a) fraction of each 40 isolated pancreatic mouse 
islets after pulse labelling of the islet proteins with [SH]leucine 
for 20 rain at a glucose concentration f300 rag%. Prior to 
the pulse, the islets were preincubated for i hr at 300 rag% 
glucose. After the pulse, the islets were washed and further 
incubated for 2 hr in fresh medium containing 0, 100 or 300 
mg% glucose. Tolbutamide (250 pg/ml) or glibenclamide 
(5 pg/ml) was added after the pulse. Fractionation of the 
islet proteins was on Sephadex G-50 fine. Essentially the same 
findings were obtained after a pulse with [ZH]leucine for 
30 rain. 
4. Discussion 
Incorporation of [aH]leucine into the proinsulin 
and insulin fraction of isolated pancreatic islets of 
mice and rats was inhibited in the presence of both 
tolbutamide and glibenclamide. This inhibition was 
also found but to a relatively lesser extent, at high 
concentrations of glucose, in contrast to Tanese et al. 
[121. 
Sulphonylureas re potent stimulators of insulin 
secretion and widely used in the control of diabetes 
meUitus. Therefore, one hesitates to interpret the in- 
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hibition of leucine incorporation i to proinsulin and 
insulin in vitro as being a true inhibition of  insulin 
biosynthesis effected by tolbutamide or glibenclamide. 
A report concerning the inhibition of  insulin secretion 
after exposure of pancreatic tissue to tolbutamide [5], 
however, would be in accordance with this explana- 
tion. The clinically known refractory states of the 
endocrine pancreas following tolbutamide application 
[7] should also be mentioned in this context. Our 
present observations were restricted to a period of 3 
hr. Hence, no conclusions can be reached from our 
experiments concerning the action of sulphonylureas 
on insulin biosynthesis after this period of time. 
Inhibition of  label uptake by the islets in presence 
of sulphonylureas would be another explanation for 
reduced incorporation of  leucine. According to Hell- 
man et al. [2], however, glibenclamide does not affect 
the net leucine Uptake of isolated pancreatic islets. 
The rate of leucine oxidation within pancreatic 
islets was found to be reduced at high glucose concen- 
trations compared to results at low concentrations 
or in the absence of glucose [3]. This fact should be 
considered when interpreting results of leucine incorpo- 
ration into proinsulin and insulin achieved at different 
glucose concentrations. 
An inhibitory action of sulphonylureas on the con- 
version of  proinsulin to insulin seems to be unlikely 
from our pulse labelling experiments. Furthermore, it
also appears that proinsulin is converted to insulin, 
irrespective of the absence or the concentration of 
glucose. Thus the site of action of tolbutamide and 
glibenclamide in our in vitro model of biosynthesis 
would seem to be located before the conversion of 
proinsulin and after the entrance of leucine into the 
B-cell. 
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